Orthofix introduced its Biologics Surgeon Advisory Board which includes seven spine surgeons, according to a Feb. 4 news release.
The board includes experts in orthopedic spine and spinal neurosurgery, and they were chosen based on their clinical experience, leadership in the spine community and recognition of the importance of biologics in spinal fusions. The group will support Orthofix’s scientific foundation and provide insights to support the biologics portfolio.
The surgeons named to the board are:
Andrew Chung, DO
Raymond Hah, MD
Phillip Louie, MD
Emmanuel Menga, MD
J. Adair Prall, MD
Harvinder Sandhu, MD
Jason Savage, MD
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
